Oxidative stress during leukocyte absorption apheresis
- 11 July 2003
- journal article
- clinical trial
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 18 (2) , 61-66
- https://doi.org/10.1002/jca.10054
Abstract
Leukocyte absorption apheresis absorbs leukocytes to the apheresis columns involving leukocyte activation. This process is regarded as bioincompatible and avoided in hemodialysis or other extracorporeal circulation processes. Thus, leukocyte apheresis has a potential risk to exacerbate in vivo oxidative stress. We evaluated the changes in plasma oxidative stress during leukocyte apheresis. Patients diagnosed as ulcerative colitis (UC) and treated with leukocyte apheresis were studied. Adacolumn (celluloseacetate beads) or Cellsorba EX (polyethylenephtarate fiber) was used for the leukocyte absorption device. Oxidative stress was measured by thiobarbituric acid reactive substances (TBARS) and hydroxyl radical (•OH) scavenging activity. Plasma samples were collected from the pre‐ and post‐column sampling port at the start, and from the pre‐column sampling port at the end of the treatment. The •OH signal intensities (OHRI) significantly increased during a column passage, indicating a loss of plasma •OH scavenging activity. However, OHRI was reduced at the end, suggesting a recovery of radical scavenging activity during leukocyte apheresis. Significant decreases of OHRI and TBARS were only observed in the early phase of the therapeutic course. No differences of OHRI and TBARS levels were observed between the two columns. These results indicate that though the plasma antioxidant activity was diminished by a column passage, plasma antioxidant activity recovers during the procedure. This efficient antioxidative effect is limited to the early phase of the therapeutic course. J. Clin. Apheresis 18:61–66, 2003.Keywords
This publication has 20 references indexed in Scilit:
- Reduced serum hydroxyl radical scavenging activity in erythropoietin therapy resistant renal anemia.Free Radical Research, 2002
- Current topics on cytapheresis technologies.Therapeutic Apheresis and Dialysis, 2001
- Dynamic changes in cytokine levels in serum and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritisJournal of Clinical Apheresis, 2001
- Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: A multicenter studyJournal of Clinical Apheresis, 2001
- Hemodialysis Does Not Influence the Peroxidative State Already Present in UremiaNephron, 2000
- Influence of the dialysis membrane on outcome of ESRD patientsAmerican Journal of Kidney Diseases, 1998
- Leukocytapheresis Therapy for Severe Ulcerative ColitisTherapeutic Apheresis, 1998
- A Role for Granulocyte and Monocyte Apheresis in the Treatment of Rheumatoid ArthritisTherapeutic Apheresis, 1998
- Granulocytapheresis in the Treatment of Patients with Rheumatoid ArthritisArtificial Organs, 1997
- Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membranesClinical and Experimental Immunology, 1994